Annual Total Long Term Liabilities
$17.65 M
-$30.67 M-63.48%
March 31, 2024
Summary
- As of February 8, 2025, LSB annual total long term liabilities is $17.65 million, with the most recent change of -$30.67 million (-63.48%) on March 31, 2024.
- During the last 3 years, LSB annual total long term liabilities has fallen by -$184.57 million (-91.27%).
- LSB annual total long term liabilities is now -93.26% below its all-time high of $261.86 million, reached on March 1, 2022.
Performance
LSB Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$14.26 M
-$39.34 M-73.39%
September 1, 2024
Summary
- As of February 8, 2025, LSB quarterly total long term liabilities is $14.26 million, with the most recent change of -$39.34 million (-73.39%) on September 1, 2024.
- Over the past year, LSB quarterly long term liabilities has stayed the same.
- LSB quarterly long term liabilities is now -94.72% below its all-time high of $269.97 million, reached on September 1, 2022.
Performance
LSB Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
LSB Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -63.5% | 0.0% |
| 3 y3 years | -91.3% | 0.0% |
| 5 y5 years | -91.3% | 0.0% |
LSB Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -93.3% | at low | -94.7% | at low |
| 5 y | 5-year | -93.3% | at low | -94.7% | at low |
| alltime | all time | -93.3% | at low | -94.7% | at low |
LakeShore Biopharma Co Ltd Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $14.26 M(-73.4%) |
| Mar 2024 | $17.65 M(-63.5%) | - |
| Sep 2023 | - | $53.60 M(+3.0%) |
| Jun 2023 | - | $52.03 M |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | $48.32 M(-81.5%) | - |
| Sep 2022 | - | $269.97 M(+3.1%) |
| Mar 2022 | $261.86 M(+29.5%) | $261.86 M |
| Mar 2021 | $202.22 M | - |
FAQ
- What is LakeShore Biopharma Co Ltd annual total long term liabilities?
- What is the all time high annual total long term liabilities for LakeShore Biopharma Co Ltd?
- What is LakeShore Biopharma Co Ltd annual total long term liabilities year-on-year change?
- What is LakeShore Biopharma Co Ltd quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for LakeShore Biopharma Co Ltd?
- What is LakeShore Biopharma Co Ltd quarterly long term liabilities year-on-year change?
What is LakeShore Biopharma Co Ltd annual total long term liabilities?
The current annual total long term liabilities of LSB is $17.65 M
What is the all time high annual total long term liabilities for LakeShore Biopharma Co Ltd?
LakeShore Biopharma Co Ltd all-time high annual total long term liabilities is $261.86 M
What is LakeShore Biopharma Co Ltd annual total long term liabilities year-on-year change?
Over the past year, LSB annual total long term liabilities has changed by -$30.67 M (-63.48%)
What is LakeShore Biopharma Co Ltd quarterly total long term liabilities?
The current quarterly long term liabilities of LSB is $14.26 M
What is the all time high quarterly long term liabilities for LakeShore Biopharma Co Ltd?
LakeShore Biopharma Co Ltd all-time high quarterly total long term liabilities is $269.97 M
What is LakeShore Biopharma Co Ltd quarterly long term liabilities year-on-year change?
Over the past year, LSB quarterly total long term liabilities has changed by $0.00 (0.00%)